The Medical Affairs and Patient Advocacy team at Catalyst Pharmaceuticals plays a crucial role in ensuring that the company's innovative therapies align with patient needs and regulatory requirements. This team conducts scientific education and communication activities to support healthcare professionals and patients, and it advocates for patient-centered initiatives, ensuring that the voices of those affected by rare diseases are heard in the development and delivery of novel treatments. By fostering collaboration between medical, regulatory, and patient communities, this team helps to enhance access to FIRDAPSE® and future therapies while advancing the company’s mission of improving patient outcomes.
View all